111YI -0.24%51 Days Payable is 29.20 as of Mar. 2026, which is 34% below its 10-year median of 44.44. GuruFocus rates YI with a GF Score™ of 51/100 and a GF Value™ of $6.66 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 115 Medical Distribution companies, 111 ranks worse than 82.61% on this metric.
111's average Accounts Payable for the
three
months ended in Mar. 2026 was $104 Mil. 111's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $324 Mil.
Hence, 111's Days Payable for the
three
months ended in Mar. 2026 was 29.20.
The historical rank and industry rank for 111's Days Payable or its related term are showing as below:
YI'
s Days Payable Range Over the Past 10 Years
Min: 31.84 Med: 44.44 Max: 46.64
Current: 42
During the past 10 years, 111's highest Days Payable was 46.64. The lowest was 31.84. And the median was 44.44.
YI's Days Payable is ranked worse than 82.61% of 115
companies
in the Medical Distribution industry
Industry Median: 79.81
vs YI: 42.00
111's Days Payable
declined
from Mar. 2025 (46.45) to Mar. 2026 (29.20).
It may suggest that 111accelerated paying its suppliers.
111 Days Payable Related Terms
111 Days Payable Historical Data
* Premium members only.
The historical data trend for 111's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, 111's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
111 Days Payable vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, 111's Days Payable distribution charts can be found below:
* The bar in red indicates where 111's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
111's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
111 (YI) has a Days Payable of 29.20 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on 111 and its competitors. This is 34% below median its historical median of 44.44. Over the past decade, 111's Days Payable has ranged from 31.84 to 46.64. According to the industry distribution chart, 111 ranks #95 out of 115 companies in the Medical Distribution industry, placing it in the top 82.6%.
Is 111's Days Payable too high?
111's current Days Payable of 29.20 is 34% below median its 10-year median of 44.44. Over the past 10 years, this metric has ranged from a low of 31.84 to a high of 46.64. The Medical Distribution industry median Days Payable is 79.81. 111's value of 29.20 is 63.4% below this industry median. Based on the distribution chart, 111 ranks #95 out of 115 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, 111 has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does 111's Days Payable compare to COSM and HKPD?
According to the Medical Distribution industry distribution chart, 111 ranks #95 out of 115 companies for Days Payable. This places 111 in the lower half of its industry. The industry median Days Payable is 79.81. 111's value of 29.20 is 63.4% below this benchmark. Historically, 111's own Days Payable has ranged from 31.84 to 46.64 over the past decade. While the company's 10-year median is 44.44 vs. the industry median of 79.81, 111 has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Distribution company?
The median Days Payable among Medical Distribution companies is 79.81, based on 115 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 111's current Days Payable of 29.20 is 63.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on 111 and its competitors. For the Medical Distribution industry, the median Days Payable is 79.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 111's current Days Payable is 29.20, which is 34% below median its own 10-year median of 44.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 111 stock overvalued right now?
Based on GuruFocus' analysis, 111 (YI) is currently considered Possible Value Trap. The stock's GF Value™ is $6.66, compared to a current price of $4.21 — trading 36.9% below its estimated fair value. The current Days Payable is 29.20, which is 34% below median its 10-year median of 44.44 and 63.4% below the Medical Distribution industry median of 79.81. 111's overall GF Score™ is 51/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For 111 (YI), the current Days Payable is 29.20 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 111 (YI) Overvalued in 2026?
Based on GuruFocus' analysis, 111 stock appears to be undervalued.
The current stock price of $4.21 is trading 36.9% below its estimated GF Value™ of $6.66.
GuruFocus considers 111 to be Possible Value Trap.
Key valuation signals for YI:
Days Payable: 29.20 (34% below median its 10-year median of 44.44)
GF Value™: $6.66 vs. price of $4.21 (36.9% below fair value)
Industry Position: 63.4% below the Medical Distribution median (#95 of 115)
No single metric tells the full story. See the YI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.
51GF Score
Get the complete analysis for YI
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
YI has been successfully added to your 
